A Phase 1 Study of TGI-5 as Monotherapy and in Combination With Nivolumab in Subjects With Locally Advanced/Metastatic Solid Tumors

Abroad (travel likely)RecruitingPHASE1

Conditions

CRC (Colorectal Cancer) · Melanoma (Skin Cancer) · HCC - Hepatocellular Carcinoma · NSCLC (Non-small Cell Lung Cancer)

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Fudan University Shanghai Cancer Center, Shanghai, China
Contact: Study coordinator (Hang Zhou, Bachelor) · hang.zhou@tgimmunopharma.com · +86-0551-62861151
Contact: Study coordinator (Xiaohu Zheng, Doctorate) · xiaohu.zheng@tgimmunopharma.com · +86-0551-62861151
Contact: Principal Investigator (Hongxia Wang, Doctorate)

Study leads

Hongxia Wang, Doctorate
Principal Investigator
Fudan University

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

The Florida ASCENT Study

Cancer · Food Deprivation · Food Habits

Abroad (travel likely)Recruiting

Gainesville, United States

Biomarker-Guided Allogeneic Single-Target or Dual-Target CAR-NK Cell Therapy for Advanced Solid Tumors

Cancer · Breast Cancer · Non-Small Cell Lung Cancer (NSCLC)

Abroad (travel likely)RecruitingPHASE1, PHASE2

Beijing, China

Predictive Value of Progastrin Titer at Diagnosis and of Progastrin Kinetics During Treatment in Cancer Patients

Cancer · Breast Cancer · Gastric Cancer

Abroad (travel likely)Recruiting

Bron, France · Lyon, France

Holistic Acupuncture for Patients With Chemotherapy Induced Nausea

Breast Cancer · Prostate Cancer · Lung Cancer

Abroad (travel likely)Recruiting

Vejle, Denmark